Sanofi, intent on slimming down, mulls $200M-plus sale of anti-inflammation meds: report kblankenship Mon, 10/19/2020 – 08:33

Agios’ Tibsovo has an FDA green light in AML. Why did European regulators turn it back? aliu Mon, […]

Pfizer plans to ditch Perth sterile injectables manufacturing site by 2024, endangering 470 positions kblankenship Mon, 10/19/2020 – […]

Over 1400 general practice registrars in Australia are being forced to re-sit their fellowship exams after the online […]

Whistleblowing on the flawed structure and process of NHS appraisal and General Medical Council revalidation is both a […]

The analysis by Tzortziou Brown and colleagues says it all1—the proposal to reintroduce appraisal and revalidation is ill […]

Dupixent, Forxiga and Opdivo were also recommended for therapeutic extensions

Chief executive of trade body warns no-deal could affect medicines supply

FDA approved therapy for newly-diagnosed acute myeloid leukaemia patients

Following completion of acquisition, site will undergo refurbishment